XRP Healthcare Acquires Pharma Ville-Retail, Wholesale Pharmacy Chain in Uganda

XRP Healthcare, a pioneering force in healthcare innovation, has officially acquired Pharma Ville, a leading retail and wholesale pharmacy chain in Uganda. XRP Healthcare has focused on integrating digital innovation with traditional pharmaceutical distribution as its bargain at revolutionizing healthcare delivery in emerging markets.

The acquisition marks a stride forward as XRP Healthcare takes on the African market with its entry in Uganda expanding its reach from the United Kingdom and the United Arab Emirates. This entry in Africa ‘s rapidly evolving healthcare sector lays a foundation for scalable, technology-driven pharmaceutical distribution across the continent.

XRP Healthcare is strategically positioned to capitalize on Africa’s healthcare market projected to reach $259 billion by 2030, and the digital health segment encompassing AI-driven solutions expected to grow to $16.6 billion.

According to Kain Roomes, CEO of XRP Healthcare, Uganda’s fragmented pharmaceutical landscape presents immense potential that by integrating Pharma Ville, delivery of impact can be immediate improving access to essential medicines and optimizing healthcare delivery.

Pharma Ville plays a pivotal role in Uganda’s healthcare sector, working closely with the National Medical Stores (NMS) and Joint Medical Stores (JMS) to ensure a steady and reliable supply of essential medicines.

Owning two retail pharmacies and five wholesale distribution centers strategically positioned across Uganda, Pharma Ville’s established infrastructure enhances medicine accessibility nationwide. Through XRP Healthcare, there is a streamlined pharmaceutical supply chains and a trajectory set to expand its footprint in Africa’s healthcare market.

The acquisition includes 60 registered pharmaceutical products, 18 products ready for immediate commercialization, and 70 additional products in the pipeline awaiting regulatory approval.

Richard Kitonsa (MPS), Founder and CEO of Pharma Ville, pointed out that the acquisition comes in as a transformative step that will entirely be impactful. “Joining XRP Healthcare is transformative. We can now rapidly scale our operations, introduce innovative technologies, and better serve Uganda’s healthcare needs,” said Richard.

By Q4, Pharma Ville will rebrand as XRP Healthcare, aligning with the company’s vision for innovation and healthcare excellence.

The XRPH AI app, a multilingual healthcare assistant, is already live and integrated into Pharma Ville’s digital platform (www.pharmaville.ai). The AI-driven tool provides medical guidance in Luganda, Swahili, Kinyarwanda, French, and English.

In an upcoming update, users will be able to upload images of medical conditions for AI-assisted preliminary assessments, with direct referrals to healthcare professionals for critical cases.

Peter Waswa, a strategic advisor to UNICEF, the Bill & Melinda Gates Foundation, and now XRP Healthcare commended the acquisition’s significance as a pillar to addressing challenges in the health care space.

“This acquisition strengthens Uganda’s healthcare sector, fosters economic growth, and introduces essential technologies to the industry. It’s a major step forward for healthcare accessibility in Uganda,” said Waswa.

Pharma Ville will undergo immediate operational upgrades, including:

Advanced inventory management to optimize supply chains
Upgraded licensing to expand product offerings
Enhanced distribution channels for wider reach
Digital payment integration for seamless transactions
New CRM systems to improve customer engagement

Laban Roomes, COO of XRP Healthcare, revealed that they have spent significant time in Uganda developing the legal and operational frameworks necessary to scale this business rapidly. “We have done the groundwork laid for expansion within Uganda and our efforts will drive long-term improvements in healthcare accessibility.”

Shonubi Musoke & Co. Advocates, one of Uganda’s premier law firms and a partner of the globally renowned Norton Rose Fulbright, advised XRP Healthcare in this transaction, ensuring a seamless legal and regulatory transition.

Additionally, Pharma Ville has distribution agreements with eight global pharmaceutical suppliers, reinforcing its strong supply chain network: